Federal health officials are considering Dr Erica Schwartz to lead the US Centers for Disease Control and Prevention (CDC), according to people familiar with th ...

Social media posts about glucagon-like peptide-1 receptor agonists may identify patient concerns not captured in clinical trials, according to a study published ...

The ACHIEVE-4 trial evaluated the efficacy and safety of orforglipron in adults with type 2 diabetes and obesity or overweight with increased risk of cardiovascular events.

Twelve recommendations issued, including suggestion for no anticoagulants for pediatric patients with solid cancer, trauma, critical illness.

The expanded labeling reinforces Caldolor’s role in multimodal analgesia, offering a non-opioid option for postoperative pain ...

The FDA is inviting manufacturers to submit sNDAs for treating decreased libido in men with idiopathic hypogonadism.

Improvement in median overall survival of 2.9 months and decrease in risk for death reported with elraglusib/GnP vs GnP alone.

One in 4 US adults report using artificial intelligence tools or chatbots for physical or mental health information, according to new research released today from the West Health-Gallup Center on ...

HealthDay News — Recommendations for the diagnosis and management of severe acquired aplastic anemia are presented in a clinical practice guideline issued by the American Society of Hematology and ...

Following favorable phase 1 data showing significant reductions in HBV DNA and RNA, the FDA has fast tracked pevifoscorvir sodium for chronic HBV infection.

30-day adjusted risk ratios for short- versus long-course antibiotic therapy not significant for mortality, readmission, urgent visit ...

Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.